| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70afeb313516869b9d19bbe743c2311e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfd71dfa3f71cc44e7471b9375b3007c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_961c3d97d21f088cfebef5e26e5545e3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2400-169
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
| filingDate |
2005-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b88a325b042437a841fccef56af84f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c59263e0871c840e69da10dd27f2ff7 |
| publicationDate |
2014-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8821893-B2 |
| titleOfInvention |
Oral vaccine for Borrelia |
| abstract |
The present invention relates to vaccines for control of Borrelia infections in animal and human populations. In particular, the present invention provides compositions and methods comprising recombinant bacteria engineered to express one or more Borrelia burgdorferi antigens for use as Lyme disease vaccines. In some embodiments, the recombinant bacteria are freeze-dried. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10857233-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11180535-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11219671-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11129906-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10954521-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10828350-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10364435-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9486513-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9737592-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9878023-B1 |
| priorityDate |
2004-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |